PDF icon PDF herunterladen
Digestive Disease Interventions 2020; 04(02): 134-147
DOI: 10.1055/s-0040-1712146
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Embolotherapy for Hepatic Oncology: Current Perspectives and Future Directions

Raazi Bajwa
1   Division of Interventional Radiology, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
,
David C. Madoff
2   Division of Interventional Radiology, Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Connecticut
,
Sirish A. Kishore
1   Division of Interventional Radiology, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
› Institutsangaben
Disclosure This work was in part funded by Dr. Madoff's NIH grant R01CA206180.
Weitere Informationen

Publikationsverlauf

12. Februar 2020

15. April 2020

Publikationsdatum:
25. Mai 2020 (online)

Auch verfügbar aufeRef
   Lizenzen und Reprints
Preview

Abstract

Primary and secondary liver cancers are a major cause of mortality worldwide. Transarterial liver-directed therapy, or embolotherapy, represents an important locoregional treatment strategy for primary and secondary liver tumors. Embolotherapeutic modalities include bland embolization (transarterial embolization), chemoembolization (transarterial chemoembolization), and radioembolization or selective internal radiotherapy. A brief technical overview of embolotherapeutic modalities as well as supportive evidence for the treatment of most common primary and secondary liver tumors will be discussed in this review. Several potential future applications, including synergy with systemic therapy, interventional theranostics, and artificial intelligence will also be reviewed briefly.

Keywords

embolization - liver cancer - locoregional therapy

Disclaimer

Since Dr. David C. Madoff is the co-Editor in Chief of the journal, Dr. Baljendra Kapoor served as ad-hoc Editor for this manuscript.